Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
Novartis
University of Pittsburgh
DEKA Biosciences
Inhibrx Biosciences, Inc
Celldex Therapeutics
Kineta Inc.
Cambridge University Hospitals NHS Foundation Trust